Takayasu arteritis, malignant hypertension and severe left ventricular hypertrophy

Int J Rheum Dis. 2019 May;22(5):951-955. doi: 10.1111/1756-185X.13541. Epub 2019 Mar 12.

Authors

José Antonio Vargas-Hitos¹, Juan Jiménez-Jáimez², Eduardo Molina Navarro², Angela Salmerón Ruiz³, Genaro López Milena³, Juan Jiménez-Alonso¹

Affiliations

¹ Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Virgen de las Nieves¨ University Hospital, Granada, Spain.
² Cardiology Department, ¨Virgen de las Nieves¨ University Hospital, Granada, Spain.
³ Radiology Department, ¨Virgen de las Nieves¨ University Hospital, Granada, Spain.

PMID: 30861323
DOI: 10.1111/1756-185X.13541

No abstract available

Keywords: Takayasu arteritis; left ventricular hyperthrophy; renal angioplasty.

Publication types

Case Reports

MeSH terms

Adult
Antihypertensive Agents / therapeutic use
Blood Pressure
Endovascular Procedures
Female
Humans
Hypertension, Malignant / diagnosis
Hypertension, Malignant / drug therapy
Hypertension, Malignant / etiology*
Hypertension, Malignant / physiopathology
Hypertrophy, Left Ventricular / diagnostic imaging
Hypertrophy, Left Ventricular / etiology*
Hypertrophy, Left Ventricular / physiopathology
Severity of Illness Index
Takayasu Arteritis / complications*
Takayasu Arteritis / diagnosis
Takayasu Arteritis / physiopathology
Takayasu Arteritis / therapy
Treatment Outcome
Ventricular Function, Left
Ventricular Remodeling

Substances

Antihypertensive Agents